We are monitoring the impact of COVID-19 & Recession alarm on MEA Preclinical In-vivo Imaging Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Preclinical In-vivo Imaging Market Research Report – Segmented By Modality, By Reagent & By Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 537
Pages: 130

MEA Preclinical In-Vivo Imaging Market Size (2022 to 2027)

The size of the preclinical in-vivo imaging market in the Middle East & Africa was estimated at USD 82.98 Million in 2022. It is projected to reach USD 109.02 Million by 2027, at a CAGR of 5.61% during the forecast period from 2022 to 2027.

Rising healthcare expenditure, increase in geriatric population, growing prevalence of cancer, and progress of R&D in imaging technologies for diagnosing various types of diseases such as cancer, are the major drivers for the MEA preclinical in-vivo imaging market growth. According to the WHO report, about 1 in 6 deaths occur due to cancer and its complications, making it the second leading cause of death globally. Approximately 70% of cancer deaths occur in low- and middle-income countries. In addition, the WHO states that around 17.95 million people die each year from cardiovascular diseases (CVD), which account for over 31% of total deaths globally.

The higher acceptance rate of multimodal in-vivo imaging systems in research studies and increased awareness of the early diagnosis of diseases are also analyzed to drive the growth of this market. Combining multiple imaging modalities in preclinical studies helps researchers understand molecular, cellular, and physiological changes in living animals and predict the outcomes of new treatments in patients. Pre-clinical in-vivo imaging is helping in drug discovery, cancer cell detection, and precision medication, supporting the market. In addition, preclinical in-vivo imaging is increasingly used in animal testing, compound optimization, and elaborate drug development.

Increased public and private sector funding have increased the adaptation of new technologies and acquisitions by different market players across the MEA region. For instance, the latest advancements in high-frequency ultrasound imaging used to detect early-stage cancer are analyzed to support high growth in the MEA preclinical in-vivo imaging market over the forecast period.

However, factors such as the strict regulatory framework governing preclinical research like the use of animals, etc., technological and procedural limitations associated with pre-clinical systems are some of the major factors restraining the growth of the MEA preclinical in-vivo imaging market. In addition, the excessive value of the product reduces adoption costs in academic institutions. High operational and maintenance costs restrain the market. Moreover, the adoption of many alternative methods and the development of computerized databases are growing rapidly, which may pose challenges for this studied market.

This research report on the MEA Preclinical In-Vivo Imaging Market is segmented and sub-segmented into the following categories:

By Modality:

  • optical Imaging
  • Nuclear Imaging
  • Micro-MRI
  • Micro-CT
  • Micro-ultrasound
  • Photoacoustic
  • Magnetic Particle Imaging Systems

By Reagent:

  • optical Imaging Reagents
  • Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Saudi Arabia is predicted to dominate the MEA preclinical in-vivo imaging market during the forecast period due to the region having developed infrastructure, many preclinical projects, large public and private companies, and higher adoption rates of technically advanced devices in this region. In addition, increasing funding for research and development coupled with a large number of research institutes is accelerating the growth of the market in Saudi Arabia.

Several factors, such as a robust R&D infrastructure for life science research, the rapid adoption of new molecular imaging technologies, the changing regulatory scenario, continued government support with funds and grants, the significant presence of pharmaceutical and biotech companies, and growing user preference for multimodal systems, are driving the growth of the preclinical in-vivo imaging market in the other MEA regions like United Arab Emirates, Qatar, Egypt, and South Africa.

KEY MARKET PLAYERS:

Companies playing an influential role in the MEA preclinical in-vivo imaging market profiled in this report are Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging and FUJIFILM VisualSonics, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures           

  1. Middle East & Africa Preclinical in-vivo imaging Market By Region, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Preclinical Optical imaging Market By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Preclinical Standalone fluorescence imaging systems Market By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Preclinical Nuclear imaging Market By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Preclinical Micro-MRI Market By Region, From 2022 - 2027 (USD Million)
  12. Middle East & Africa Preclinical Micro-CT Market By Region, From 2022 - 2027 (USD Million)
  13. Middle East & Africa Preclinical Micro-ultrasound Market By Region, From 2022 - 2027 (USD Million)
  14. Middle East & Africa Preclinical Photoacoustic Market By Region, From 2022 - 2027 (USD Million)
  15. Middle East & Africa Preclinical Magnetic particle imaging systems Market By Region, From 2022 - 2027 (USD Million)
  16. Middle East & Africa Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  17. Middle East & Africa Preclinical Optical imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  18. Middle East & Africa Preclinical Bioluminescent reagents Market By Region, From 2022 - 2027 (USD Million)
  19. Middle East & Africa Preclinical Fluorescent imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  20. Middle East & Africa Preclinical Nuclear imaging reagents Market By Region, From 2022 - 2027 (USD Million)
  21. Middle East & Africa Preclinical PET tracers Market By Region, From 2022 - 2027 (USD Million)
  22. Middle East & Africa Preclinical SPECT probes Market By Region, From 2022 - 2027 (USD Million)
  23. Middle East & Africa Preclinical MRI contrast agents Market By Region, From 2022 - 2027 (USD Million)
  24. Middle East & Africa Preclinical Ultrasound contrast agents Market By Region, From 2022 - 2027 (USD Million)
  25. Middle East & Africa Preclinical CT contrast agents Market By Region, From 2022 - 2027 (USD Million)
  26. Middle East Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  27. Middle East Preclinical Optical Imaging Market By Optical imaging, From 2022 - 2027 (USD Million)
  28. Middle East Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2022 - 2027 (USD Million)
  29. Middle East Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  30. Middle East Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2022 - 2027 (USD Million)
  31. Middle East Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2022 - 2027 (USD Million)
  32. Africa Preclinical in-vivo imaging Market By Modality, From 2022 - 2027 (USD Million)
  33. Africa Preclinical Optical Imaging Market By Optical imaging, From 2022 - 2027 (USD Million)
  34. Africa Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2022 - 2027 (USD Million)
  35. Africa Preclinical in-vivo imaging Market By Reagent, From 2022 - 2027 (USD Million)
  36. Africa Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2022 - 2027 (USD Million)
  37. Africa Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample